Comparison of the predictive value of four insulin resistance surrogates and hyperuricemia in women with recurrent pregnancy loss: A cross‐sectional study
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.16061 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Mei Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou, China. Hauptthemen laut MEDLINE: Abortion, Habitual, Insulin Resistance, Hyperuricemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special Fund for Doctoral Student Training of The Second Hospital of Lanzhou University in 2019, The Innovation and Development Project of Medical Postgraduate Training of Lanzhou University.
Abstract (Originalsprache)
Background
Insulin resistance (IR), hyperuricemia (HUA), and recurrent pregnancy loss (RPL) elevate the risk of cardiovascular disease and metabolic disorders, while also impacting reproductive health. The relationship between IR, HUA, and RPL has not been thoroughly investigated. This study investigates the relationship between four IR surrogates and the risk of HUA in RPL patients.
Methods
Data from a real‐world study on RPL in China were analyzed using multivariable regression to determine the relationship between HUA and triglyceride and glucose (TyG) index, triglyceride glucose‐body mass index (TyG‐BMI), triglyceride to high‐density lipoprotein cholesterol (TG/HDL‐c) ratio, and metabolic score for insulin resistance (METS‐IR). The predictive ability of these surrogates for detecting HUA in RPL patients was evaluated using the area under the curve and receiver operating characteristic analysis. Sensitivity analysis was performed using bootstrapping resampling.
Results
The study included 769 patients with a mean age of 30 ± 4 years old, 8.32% of whom had HUA. Four IR surrogates were closely related to HUA in patients of RPL after adjusting for age, menstrual cycle, creatinine, alanine transaminase, aspartate transaminase, total cholesterol, homocysteine, and low‐density lipoprotein, with area under the curve values of TyG index (OR = 0.693, 95% confidence interval [CI]: 0.626, 0.759), TyG‐BMI (OR = 0.731 95% CI: 0.657, 0.805), TG/HDL‐C (OR = 0.703, 95% CI: 0.641, 0.764), and METS‐IR (OR = 0.728, 95% CI: 0.655, 0.799). Bootstrap resampling yielded similar results.
Conclusions
The TyG index, TyG‐BMI, TG/HDL‐c, and METS‐IR significantly correlated with HUA in patients with RPL. The TyG‐BMI had the highest predictive value of the four IR surrogates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou, China.
- Obstetrics and Gynaecology Intensive Care Unit, Gansu Maternal and Child Health Hospital, Lanzhou, China.
ORCID-Profile: Fang Wang
Förderung
- Special Fund for Doctoral Student Training of The Second Hospital of Lanzhou University in 2019
- The Innovation and Development Project of Medical Postgraduate Training of Lanzhou University
Zitieren
APA
Wang, M., Mu, F. X., & Wang, F. (2024). Comparison of the predictive value of four insulin resistance surrogates and hyperuricemia in women with recurrent pregnancy loss: A cross‐sectional study. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16061
Vancouver
Wang M, Mu FX, Wang F. Comparison of the predictive value of four insulin resistance surrogates and hyperuricemia in women with recurrent pregnancy loss: A cross‐sectional study. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16061
BibTeX
@article{Wang2024,
author = {Wang, Mei and Mu, Fang-Xiang and Wang, Fang},
title = {Comparison of the predictive value of four insulin resistance surrogates and hyperuricemia in women with recurrent pregnancy loss: A cross‐sectional study},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.16061}
}
EUVIMED